An official website of the United States government

(3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-8-(ureidomethylene)-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide; (3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-2-methyl-3,6,9,12,16-pentaoxo-8-(ureidomethylene)-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide

PubChem SID
602894
Structure
(3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-8-(ureidomethylene)-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide; (3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-2-methyl-3,6,9,12,16-pentaoxo-8-(ureidomethylene)-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide_small.png
External ID
Source Category

Curation Efforts

Governmental Organizations

Research and Development

Version
Status
Live
Related Compounds
PubChem CID
CID 135483770 (Capreomycin Sulfate Standard)
Component CID
Dates
  • Deposit:
    2004-09-15
  • Modify:
    2015-01-21
  • Available:
    2005-03-27
Description
Please note that the substance record is presented as provided to PubChem by the source (depositor). For standardized chemical structure and/or annotation information, please visit the summary page for CID 135483770.

1 2D Structure

Chemical Structure Depiction
(3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-8-(ureidomethylene)-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide; (3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-2-methyl-3,6,9,12,16-pentaoxo-8-(ureidomethylene)-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide.png

2 Identity

2.1 Source

2.2 External ID

2.3 Source Category

Curation Efforts

Governmental Organizations

Research and Development

2.4 Depositor-Supplied Synonyms

2.5 Deposit Date

2004-09-15

2.6 Modify Date

Version 1
Version 2
Version 3
Version 4
Version 5
Version 6
Version 7
2015-01-21 (currently shown)

2.7 Available Date

2005-03-27

2.8 Status

Live

3 Depositor Comments

NIAID ChemDB HIV, Opportunistic Infections and Tuberculosis Therapeutics Database

ISOLATED FROM STREPTOMYCES CAPREOLUS; OR SULFATE; MIXTURE OF CAPREOMYCINS IA (STRUCTURE WITH SERINE)(25%), IB (STRUCTURE WITH ALANINE)(67%), IIA (2%) AND IIB (6%)

Mycins

Natural Products, Microbial

5 Literature

5.1 Depositor Provided PubMed Citations

6 Biological Test Results

6.1 BioAssay Results

7 Information Sources

CONTENTS